ID
16752
Description
Boceprevir (SCH 503034) Plus Peg-Intron, With and Without Added Ribavirin, in Patients With Chronic Hepatitis C, Genotype 1, Who Did Not Respond to Previous Treatment With Peginterferon Alfa Plus Ribavirin (Study P03659AM2)(COMPLETED); ODM derived from: https://clinicaltrials.gov/show/NCT00160251
Link
https://clinicaltrials.gov/show/NCT00160251
Keywords
Versions (1)
- 8/3/16 8/3/16 -
Uploaded on
August 3, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Chronic Hepatitis C NCT00160251
Eligibility Chronic Hepatitis C NCT00160251
- StudyEvent: Eligibility
Similar models
Eligibility Chronic Hepatitis C NCT00160251
- StudyEvent: Eligibility
C0919875 (UMLS CUI [1,2])
C1875630 (UMLS CUI [1,3])
C0193388 (UMLS CUI [1,2])
C0459422 (UMLS CUI [1,2])
C0022885 (UMLS CUI [2,1])
C0459422 (UMLS CUI [2,2])
C0687130 (UMLS CUI [1,2])
C0006147 (UMLS CUI [1,2])
C0275524 (UMLS CUI [2,1])
C0019682 (UMLS CUI [2,2])
C0275524 (UMLS CUI [3,1])
C0019163 (UMLS CUI [3,2])
C0085756 (UMLS CUI [4])
C2746051 (UMLS CUI [1,2])
C0019196 (UMLS CUI [2,1])
C0033607 (UMLS CUI [2,2])
C0009488 (UMLS CUI [2])